Sign in

CIK 0001837607

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

AEON Biopharma, Inc.

Sign in to watch
Ticker
AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853940478
Phone
+1 949-354-6499
Business address
130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
Former names
Priveterra Acquisition Corp.
Open-market buys, last 90 days
$57,054
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$57,054. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Oh Chad CHIEF MEDICAL OFFICER Grant or award +1,316,872 2,183,436
2026-02-17 Oh Chad CHIEF MEDICAL OFFICER Grant or award +862,500 866,564
2025-05-21 Oh Chad Chief Medical Officer Grant or award · Restricted Stock Units +1,316,872 1,316,872
2024-08-31 Oh Chad CHIEF MEDICAL OFFICER Grant or award +192,117 292,545
2024-08-31 Oh Chad CHIEF MEDICAL OFFICER Grant or award · Stock Option +512,673 512,673
2024-03-19 Oh Chad CHIEF MEDICAL OFFICER Grant or award · Stock Option +86,720 86,720
2023-07-21 Oh Chad Chief Medical Officer Grant or award · Stock Option +145,588 145,588
2023-07-21 Oh Chad Chief Medical Officer Grant or award · Stock Option +115,151 115,151
2023-07-21 Oh Chad Chief Medical Officer Grant or award · Restricted Stock Units +100,428 100,428

Page 1 of 1 · 9 trades